Literature DB >> 22788418

Plasma IP-10 is associated with rapid disease progression in early HIV-1 infection.

Yanmei Jiao1, Tong Zhang, Rui Wang, Hongwei Zhang, Xiaojie Huang, Jiming Yin, Liguo Zhang, Xiaoning Xu, Hao Wu.   

Abstract

Cytokines play key roles in modulating disease progression in simian immunodeficiency virus/human immunodeficiency virus (SIV/HIV) infection. There are a few studies on the relationship between early cytokines and HIV disease prognosis. In this study, we first report the relationship based on two groups with clearly different disease progression. We found that IP-10 was the only cytokine among the 26 cytokines tested that was always positively correlated with disease progression, and was associated with the time for CD4 counts to fall below 200 cells/μL during Fiebig stages III-V in HIV-1 infection. This suggests that high IP-10 levels in the blood are associated with rapid disease progression during Fiebig stages III-V in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22788418     DOI: 10.1089/vim.2012.0011

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  39 in total

1.  Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial.

Authors:  Rupak Shivakoti; Erin R Ewald; Nikhil Gupte; Wei-Teng Yang; Cecilia Kanyama; Sandra W Cardoso; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R Lama; Umesh Lalloo; Fatima Zulu; Jyoti S Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Richard Pollard; Barbara Detrick; Ashwin Balagopal; David M Asmuth; Richard D Semba; Thomas B Campbell; Jonathan Golub; Amita Gupta
Journal:  Clin Nutr       Date:  2018-05-29       Impact factor: 7.324

2.  Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling.

Authors:  Erica S Lovelace; Jessica Wagoner; James MacDonald; Theo Bammler; Jacob Bruckner; Jessica Brownell; Richard P Beyer; Erika M Zink; Young-Mo Kim; Jennifer E Kyle; Bobbie-Jo M Webb-Robertson; Katrina M Waters; Thomas O Metz; Federico Farin; Nicholas H Oberlies; Stephen J Polyak
Journal:  J Nat Prod       Date:  2015-07-17       Impact factor: 4.050

3.  Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.

Authors:  Erin M Kahle; Michael Bolton; James P Hughes; Deborah Donnell; Connie Celum; Jairam R Lingappa; Allan Ronald; Craig R Cohen; Guy de Bruyn; Youyi Fong; Elly Katabira; M Juliana McElrath; Jared M Baeten
Journal:  J Infect Dis       Date:  2014-11-10       Impact factor: 5.226

4.  Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.

Authors:  Ashwin Balagopal; David M Asmuth; Wei-Teng Yang; Thomas B Campbell; Nikhil Gupte; Laura Smeaton; Cecilia Kanyama; Beatriz Grinsztejn; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R Lama; Umesh G Lalloo; Fatima Zulu; Jyoti S Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Xiao-Dong Li; Richard B Pollard; Richard D Semba; David L Thomas; Robert C Bollinger; Amita Gupta
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

5.  Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy.

Authors:  Babafemi Taiwo; Roy M Matining; Lu Zheng; Michael M Lederman; Charles R Rinaldo; Peter S Kim; Baiba I Berzins; Daniel R Kuritzkes; Amy Jennings; Joseph J Eron; Cara C Wilson
Journal:  J Antimicrob Chemother       Date:  2013-04-18       Impact factor: 5.790

6.  A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.

Authors:  Stephanie M Dillon; Kejun Guo; Gregory L Austin; Sara Gianella; Phillip A Engen; Ece A Mutlu; John Losurdo; Garth Swanson; Prachi Chakradeo; Ali Keshavarzian; Alan L Landay; Mario L Santiago; Cara C Wilson
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

7.  Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.

Authors:  Kerry J Lavender; Kathrin Gibbert; Karin E Peterson; Erik Van Dis; Sandra Francois; Tyson Woods; Ronald J Messer; Ali Gawanbacht; Janis A Müller; Jan Münch; Katie Phillips; Brent Race; Michael S Harper; Kejun Guo; Eric J Lee; Mirko Trilling; Hartmut Hengel; Jacob Piehler; Jens Verheyen; Cara C Wilson; Mario L Santiago; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

8.  Plasma interferon-gamma-inducible protein 10 can be used to predict viral load in HIV-1-infected individuals.

Authors:  Clive M Gray; Heather A Hong; Katherine Young; David A Lewis; Dorothy Fallows; Claudia Manca; Gilla Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

9.  Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation.

Authors:  Jyoti S Mathad; Nikhil Gupte; Ashwin Balagopal; David Asmuth; James Hakim; Breno Santos; Cynthia Riviere; Mina Hosseinipour; Patcharaphan Sugandhavesa; Rosa Infante; Sandy Pillay; Sandra W Cardoso; Noluthando Mwelase; Jyoti Pawar; Sima Berendes; Nagalingeswaran Kumarasamy; Bruno B Andrade; Thomas B Campbell; Judith S Currier; Susan E Cohn; Amita Gupta
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

Review 10.  Evolution and Diversity of Immune Responses during Acute HIV Infection.

Authors:  Samuel W Kazer; Bruce D Walker; Alex K Shalek
Journal:  Immunity       Date:  2020-11-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.